AZD6621
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD6621, covering 2026-02-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer [Phase 1, Phase 2]